FDA Announces Approval for Informed Consent Guidance on Leftover Human Specimens

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to informed consent for in vitro diagnostic device studies using leftover human specimens that are not individually identifiable. This approval is under the Paperwork Reduction Act of 1995.